Properties
Description
CB 300919 is a potential therapy for ovarian cancer. The molecular weight of the compound is 584.11, and its molecular formula is C32H34ClN7O2.
Molecular Formula
C32H34ClN7O2
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
CB 300919 plays a key role in inhibiting the release of pro-inflammatory cytokines and thus reducing inflammation.